UPDATE 2-Sanofi's diabetes drug Toujeo gets U.S. approval, label disappoints
February 26, 2015 at 18:35 PM EST
Feb 26 (Reuters) - French drugmaker Sanofi SA's new Toujeo diabetes drug won U.S. regulatory approval, but with wording on its prescribing label that analysts say could make marketing difficult.